Frisco, Texas, March 31, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), today announced financial and operating results for the fourth quarter and year ended December 31, 2014.
Fiscal Year 2014 Highlights:
• Revenues were $2.4 million, up 35%, led by an 83% increase in revenues in the US
• 10th consecutive quarter of sales growth
• Gross profit was 56% on an adjusted basis
• General & administrative expense was $1.75 million
• Cash was at $647,093
• Capital leases decreased by $309,534
• Long term debt down 42%
• Working capital was a surplus of $418,734
• Current ratio was 1.3
• Total assets increased 7% to $2.5 million
• Net loss per share for the year was $0.10
• Model 615 shipments up 18%; Replacement cartridge shipments up 35%
• Replacement cartridges up to 144% of Model 615 shipped
OxySure to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call at 9:00 am ET on March 31, 2015
FRISCO, TX--(Marketwired - March 25, 2015) - OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that it will hold a conference call at 9:00 am ET on Tuesday, March 31, 2015 to discuss its financial results for the three and twelve months ended December 31, 2014.
Mr. Julian Ross, CEO of OxySure, will host the conference call. To join the Audio Conference, please dial the phone number ten minutes prior to the start of the conference call and enter your passcode as follows:
Audience Dial-In: 1 (800) 697-5978 Audience US Toll Free 1 (630) 691-2750 Audience US Toll
Audience Passcode: 6079 959
FRISCO, TX--(Marketwired - March 02, 2015) - OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that the Company has been invited to present at the 27th Annual ROTH Conference. Chairman & CEO, Julian T. Ross, and Vice President of Resuscitation Sales, Clark Hood will present a business overview and update on March 11, 2015 at 12:30pm Pacific Time at The Ritz Carlton Hotel Laguna Niguel, located at 1 Ritz Carlton Drive, Dana Point, California. Mr. Ross and Mr. Hood will also be available for one-on-one meetings at the conference on Tuesday March 10 and Wednesday March 11, 2015
FRISCO, TX--(Marketwired - February 18, 2015) - OxySure Systems, Inc. (OXYS) ("OxySure," or the "Company"), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that the Company has signed a distribution agreement with Stop Heart Attack of Birmingham, Alabama.
It’s an enormous 3D printer which can create an object the size of a phone booth. With a build volume of 1800 x 1000 x 700 mm, the ExOne S-Max printer can, within 24 hours, produce parts of complex shapes and large volumes.
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that the Company has signed a distribution agreement with Chris Gardner and Associates, LLC ("CGA") of Wilton, Connecticut.
CGA is a Veteran owned business that was founded by Chris Gardner, a former EMT and EMS Instructor. CGA is an American Heart Association BLS (Basic Life Support) Instructor and is an Authorized supplier of automated external defibrillators (AEDs) for Cardiac Science, HeartSine, Philips Medical, Physio-Control, and Zoll. Said Clark Hood, VP of Resuscitation Sales for OxySure: "As a former paramedic Chris has a strong background in emergency medical services. We look forward to working with Chris and his team as they target "placement" markets such as school systems, religious organizations, municipalities, corporations, yacht and boat clubs, athletic clubs, sports facilities, and golf clubs."
Nuverra Environmental Solutions (NYSE:NES) was upgraded by equities researchers at Hilliard Lyons from an “underperform” rating to a “neutral” rating in a research report issued on Monday.
"Cardio Partners gives us additional strong in our representation in the Midwest," said Clark Hood, VP of Resuscitation Sales for OxySure. "They bring well over a decade of experience in the placement and management of thousands of AEDs throughout Chicago and across the United States. By adding OxySure to their product portfolio, they now can offer a unique and proprietary resuscitation product to their existing and new customers."
Said Brian Leonard, President and CEO of Cardio Partner Resources: "We are excited about our distribution contract for the OxySure Model 615 portable emergency oxygen device. The Model 615 is FDA approved for OTC (over the counter) use and is a perfect companion product to new and existing AED programs. We can now offer a viable solution to our clients to make the administration of emergency oxygen simple and safe in the work environment."
SeeThruEquity Issues Update Note on OxySure Systems:
"We are maintaining our price target of $2.30 for OxySure. We see the company as a compelling medical device company in the small cap healthcare sector with an innovative medical device with several catalysts ahead. We have modeled strong growth in 2015E; our model calls for the top line to grow from $3.1mn in 2014E, which would represent growth of 72.2% from 2013 levels. Oxysure's management has also reiterated its goal to reach an annual run rate of $10.0mn in 2015E, and we are encouraged by the recent steps taken by the company to achieve this goal. Our target of $2.30 suggests potential upside of 233.3% from the recent price of $0.69 on January 21, 2015."